Vifor Pharma Investor Presentation November 2021

Vifor Pharma presents its leading portfolio in target therapy areas including iron deficiency, nephrology, and cardio-renal markets. The presentation outlines the company's strategic focus as a global market leader with high unmet medical needs, featuring commercial products like Ferinject® and a robust pipeline including avacopan, vadadustat, and sparsentan across multiple therapeutic areas.